Group 1 - The company announced the approval of the proposal to reappoint the auditing firm for the fiscal year 2025 during the 14th meeting of the 8th Supervisory Board [2]

Group 1 - The company held its 22nd meeting of the 8th Board of Directors on September 4, 2025, to discuss various investment proposals [2][5][30] - The Board approved the establishment of a subsidiary, Dongying Shenghua Lida Technology Co., Ltd., to invest in a 53,000 tons/year calcium chloride project with a total investment of 25 million yuan [26][29] - The project is expected to have an annual output value of approximately 23.57 million yuan and an estimated profit of 4.87 million yuan after reaching full production [29] Group 2 - The company also approved the signing of an investment cooperation agreement with Tengzhou Tianshui Biotechnology Co., Ltd. to establish a joint venture, Jining Shengying Chemical Products Trading Co., Ltd., with a registered capital of 6 million yuan [36][37] - The company plans to use raised funds to replace pre-invested self-raised funds and expenses related to the issuance of shares, which complies with relevant regulations [73][76] - The company has proposed to reappoint Lixin Certified Public Accountants as the auditing firm for the year 2025, pending approval from the shareholders' meeting [81][92]

Key Points - Zhonghuan Hailu terminated the planning of the change of company control and resumed trading [1][2] - Shida Shenghua plans to establish a subsidiary with an investment of 25 million yuan to build a 53,000 tons/year calcium chloride project [1] - Southeast Network Frame won a bid for approximately 1.686 billion yuan for the Pujiang Street Five Villages joint planning and development project [1] - Roman Co. intends to acquire 39.2308% equity of Wutong Gaoxin for 196 million yuan [1] - Torch Electronics completed a share repurchase, having repurchased shares worth 49.9907 million yuan [1] - Jiangling Motors reported cumulative sales of 226,500 vehicles from January to August, a year-on-year increase of 5.67% [1] - Wen's Co. reported August sales revenue of 2.956 billion yuan for broilers and 4.825 billion yuan for live pigs [2] - Some directors and senior management of Shanghai Caishi plan to increase their holdings by no less than 6 million yuan [1] - Actual controller of Gongdong Medical, Shi Huiyong, plans to reduce holdings by no more than 4.4099 million shares through block trading [1] - Shida Shenghua's subsidiary establishment and investment in the calcium chloride project indicates growth in the chemical industry [1]

Group 1 - Guoxin Technology successfully tested a new generation of automotive electronic BLDC motor drive control high-performance chip "CBC2100B," which is based on 130nm BCD process and aims to address the MCU chip shortage in China's automotive industry, especially in new energy vehicles [1] - The chip is applicable in automotive electronic fields such as water pumps, oil pumps, and air conditioning fans, as well as in industrial control for BLDC motor drives and electrified equipment [1] Group 2 - Hangzhou High-tech experienced a change in control with the resignation of multiple key executives, including the chairman, vice chairman, and general manager, which may lead to a temporary reduction in the board's member count below the minimum required [2] - The resigning executives will continue to perform their duties until new appointments are made to ensure the company's normal operations [2] Group 3 - Zhonghuan Hailu decided to terminate the planning of a change in control due to disagreements with the trading party regarding future development arrangements [4] - The stock and convertible bonds of the company will resume trading on September 5, 2025 [4] Group 4 - ST Tianmao plans to voluntarily withdraw its A-shares from trading on the Shenzhen Stock Exchange and apply for transfer to the National SME Share Transfer System after the termination of listing [5] - The decision has been approved by the company's first temporary shareholders' meeting in 2025 [5] Group 5 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang to explore AI computing power collaboration and the development of industrial manufacturing and decision-making AI vertical models [6] - Hunan Baiyin adjusted its share repurchase price ceiling from 5 yuan to 7 yuan per share due to the stock price exceeding the original limit [6] Group 6 - Dongnan Network won the bid for the "Pujiang Street Five Villages Joint Development Project" with a bid amount of 1.686 billion yuan, accounting for 15% of the company's audited revenue for 2024 [8] - Wens Foodstuff reported sales of 3.2457 million pigs in August 2025, generating revenue of 4.825 billion yuan, with a year-on-year price change of 37.88% [8] - Jiangling Motors sold 30,003 vehicles in August 2025, representing a year-on-year increase of 8.92% [8] Group 7 - Hubei Yihua completed the construction of a 200,000 tons/year caustic soda energy-saving renovation project, which has been put into production [9] - Satellite Chemical announced routine maintenance for its polyethylene and ethylene oxide/ethylene glycol facilities, expected to last 45 days [9] Group 8 - Shida Shenghua plans to establish a subsidiary for a 53,000 tons/year calcium chloride project with an investment of 25 million yuan, aimed at enhancing its resource advantages in the new energy materials sector [11] - Roman Co. intends to acquire a 39.2308% stake in Wutong Technology for 196.154 million yuan, which will make Wutong a subsidiary of Roman [11] Group 9 - Shanghai Laishi's executives plan to increase their shareholdings in the company with a total investment of no less than 6 million yuan [13]

Core Viewpoint - The company has signed an investment cooperation agreement with Tengzhou Tianshui Biotechnology Co., Ltd. to establish a joint venture named Jining Shengying Chemical Products Trading Co., Ltd. in Jining, with a registered capital of RMB 6 million [1][2]. Investment Overview - The joint venture will have a registered capital of RMB 6 million, with Shandong Shenghua Guohong New Materials Co., Ltd. contributing RMB 3.3 million (55% ownership) and Tengzhou Tianshui contributing RMB 2.7 million (45% ownership) [2][5]. - The board of directors approved the investment agreement with a unanimous vote of 9 in favor, with no opposition or abstentions [2]. Partner Company Information - Tengzhou Tianshui Biotechnology Co., Ltd. was established on September 15, 2011, and is located in Tengzhou, specializing in food additives and chemical products [2][3]. - The company is a limited liability company with a registered capital of RMB 15 million, primarily owned by Yang Jingchun (92%) and Zhang Xiangzhou (8%) [3]. Joint Venture Governance Structure - The joint venture will have one director and one supervisor, with the director nominated by Shenghua Guohong and the supervisor by Tianshui [6]. - The manager of the joint venture will also serve as the legal representative and will be nominated by Shenghua Guohong [6]. Profit Distribution and Loss Sharing - The joint venture will allocate 10% of its after-tax profits to statutory reserves until the reserves reach 50% of the registered capital, after which it may cease to allocate [6]. - In the event of losses, shareholders will bear limited liability up to their respective contributions [6]. Rights and Obligations - Shareholders have the right to correct any actions that infringe on their interests and are obligated to make additional investments if required [7]. - Shareholders have a priority right to purchase shares if any shareholder intends to transfer their shares [8]. Impact on Company Performance - The investment agreement is expected to enhance the competitive strengths of both parties and is viewed positively for the long-term development of the company [12]. - The agreement is not anticipated to have a significant impact on the company's operating performance for the year 2025 [13].

证券代码：603026 证券简称：石大胜华 公告编号：临 2025-056 石大胜华新材料集团股份有限公司 事务所（特殊普通合伙）于 2025 年 8 月 4 日进行了审验，并出具《验资报告》 （信会师报字[2025]第 ZG12714 号）。为规范公司募集资金管理，保护投资者权 益，公司及子公司与保荐人、募集资金专户开户银行签署了《募集资金专户存储 三方监管协议》，开设了募集资金专项账户，对募集资金实行专户存储。 二、本次募集资金金额与用途 根据《石大胜华新材料集团股份有限公司向特定对象发行股票募集说明书》 及《关于调整公司 2022 年度向特定对象发行 A 股股票方案的议案》，调整后的 向特定对象发行股票募集资金总额不超过 1,000,000,000.00 元（含本数）。发 行人本次向特定对象发行实际募集资金总额为 999,999,976.34 元，由于本次发 行募集资金扣减发行费用后的实际募集资金净额略低于《关于调整公司 2022 年 度向特定对象发行 A 股股票方案的议案》调整后募投项目拟使用募集资金的金额， 根据实际募集资金净额，结合公司目前经营发展战略规划和实际经营需要，为保 证募投项目顺利实施， ...

Investment Overview - The company plans to establish a subsidiary, Dongying Shenghua Lida Technology Co., Ltd., to invest in a 53,000 tons/year calcium chloride project [1][2] - The total investment for the project is estimated at 25 million yuan, with funding sourced from the company's own capital [1][2] - The project will be located in Dongying City, Shandong Province, covering an area of 5,300 square meters, with a construction period of 8 months [1] Financial Projections - The projected annual revenue from the calcium chloride product is approximately 23.57 million yuan [3] - Total estimated costs for the project are around 17.07 million yuan, leading to an expected profit of approximately 4.87 million yuan annually [3] Board Approval - The investment proposal was approved by the board with 9 votes in favor and 0 against, and does not require further approval from the shareholders' meeting [4] Strategic Impact - This investment is expected to enhance the company's resource advantages in the new energy materials sector, increase product value, and improve profitability, thereby strengthening the company's core competitiveness [4]

Core Viewpoint - The company plans to reappoint Lixin Certified Public Accountants (Special General Partnership) as its auditing firm for the year 2025, pending approval from the shareholders' meeting [1][6]. Group 1: Auditing Firm Information - Lixin Certified Public Accountants was founded in 1927 by Dr. Pan Xulun and is a member of the international accounting network BDO [1]. - As of the end of 2024, Lixin has 296 partners, 2,498 registered accountants, and a total of 10,021 employees [2]. - Lixin's audited business revenue for 2024 was 4.748 billion yuan, with auditing revenue at 3.672 billion yuan and securities business revenue at 1.505 billion yuan [2]. Group 2: Legal and Risk Management - Lixin has set aside a professional risk fund of 171 million yuan and has a cumulative compensation limit of 1.05 billion yuan for professional insurance, which covers civil liability due to audit failures [2]. - In the past three years, Lixin has faced five administrative penalties and 43 supervisory measures, but has not faced any criminal penalties [5]. Group 3: Audit Fee Structure - The audit fee for the annual report is set at 550,000 yuan, and the internal control audit fee is also 300,000 yuan, both showing no percentage change [5]. Group 4: Board and Committee Opinions - The company's audit committee has reviewed Lixin and believes it adheres to independent auditing principles, reflecting the company's financial status objectively [5]. - The board of directors approved the proposal to reappoint Lixin with a unanimous vote of 9 in favor, 0 against, and 0 abstentions [6].

Core Viewpoint - The report provides a verification of Shida Shenghua New Materials Group Co., Ltd.'s use of raised funds to replace self-raised funds previously invested in projects and to cover issuance expenses, confirming compliance with relevant regulations [3][4][6]. Group 1: Fundraising Overview - The company issued a total of 30,021,014 A-shares at a price of RMB 33.31 per share, raising approximately RMB 999.99 million, with net proceeds after deducting issuance costs amounting to RMB 982.17 million [7][8]. - The total expected investment for the projects funded by the raised capital is RMB 270,041.46 million, with RMB 100 million planned to be allocated from the raised funds [8][9]. Group 2: Fund Utilization and Adjustments - The company has pre-invested a total of RMB 1,225,474,318.47 using self-raised funds, with plans to replace RMB 682,169,508.71 of this amount with the raised funds [9][10]. - Due to the actual raised amount being lower than initially expected, the company adjusted the planned allocation of the raised funds from RMB 100 million to RMB 98.22 million [9].

Summary of Key Points Core Viewpoint - The company is utilizing raised funds to replace pre-invested self-raised funds for investment projects and previously paid issuance expenses, following regulatory requirements and internal approvals [1][5][7]. Group 1: Fundraising Overview - The company received approval from the China Securities Regulatory Commission to issue shares to specific targets, with a total fundraising amount not exceeding 1,990 million yuan [1]. - The actual amount raised from the issuance was 999,999,976.34 yuan, with net proceeds after deducting issuance costs amounting to 982,169,508.71 yuan [2][3]. Group 2: Investment Project Details - The total planned investment for the projects was 270,041.46 million yuan, with the adjusted amount for the projects being 100,000 million yuan, and the actual investment amounting to 98,216.95 million yuan [2][3]. Group 3: Use of Self-raised Funds - The company pre-invested a total of 1,225,474,318.47 yuan from self-raised funds into the projects, with a planned replacement amount of 682,169,508.71 yuan [3][4]. - The total issuance costs amounted to 17,830,467.63 yuan, of which 6,235,868.87 yuan was paid from self-raised funds, which will also be replaced by the raised funds [4][5]. Group 4: Approval and Compliance - The board of directors and the supervisory board approved the use of raised funds to replace pre-invested self-raised funds, confirming compliance with relevant regulations [5][7]. - The time frame for the replacement of funds does not exceed six months from the transfer to the special account, ensuring no alteration in the intended use of funds [5][7]. Group 5: Verification by Accounting Firm - The accounting firm provided a verification report confirming that the company's management complied with regulatory requirements regarding the use of raised funds [6][7].